Detalhe da pesquisa
1.
Somatic STAT3 mutations in large granular lymphocytic leukemia.
N Engl J Med
; 366(20): 1905-13, 2012 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-22591296
2.
Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia.
Blood
; 121(22): 4541-50, 2013 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-23596048
3.
The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia.
Haematologica
; 100(1): 91-9, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25281507
4.
High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia.
Blood
; 128(20): 2465-2468, 2016 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27697773
5.
STAT3 Mutation Is Associated with STAT3 Activation in CD30+ ALK- ALCL.
Cancers (Basel)
; 12(3)2020 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32188095
6.
CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia.
Biomark Res
; 8: 54, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33110606
7.
Patient-Customized Drug Combination Prediction and Testing for T-cell Prolymphocytic Leukemia Patients.
Cancer Res
; 78(9): 2407-2418, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29483097
8.
Divergent roles for antigenic drive in the aetiology of primary versus dasatinib-associated CD8+ TCR-Vß+ expansions.
Sci Rep
; 8(1): 2534, 2018 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29416058
9.
Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.
Nat Commun
; 9(1): 1567, 2018 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29674644
10.
Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors.
Oncotarget
; 8(14): 22606-22615, 2017 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28186983
11.
A guilt-by-association mutation network in LGL leukemia.
Oncotarget
; 8(55): 93299-93300, 2017 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29212142